Cromolyn Dosage

Medically reviewed by Drugs.com. Last updated on Sep 12, 2024.

Usual Adult Dose for Asthma - Maintenance

Administer 20 mg (1 vial) via nebulizer 4 times a day at regular intervals

Prophylaxis of acute bronchospasm due to exercise, exposure to cold dry air, or environmental allergens: 20 mg (1 vial) via nebulizer shortly before anticipated exposure

Comments:

• This drug is a prophylactic agent to be used in patients whose symptoms are sufficiently frequent to require a continuous regimen of medications; the effect is usually evident after several weeks, although some patients show an almost immediate response.
• This drug should not be added to a therapeutic regimen during an acute episode; therapy should be started once asthma is controlled, the airway is cleared, and the patient is able to inhale adequately.

Use: For the management of bronchial asthma

Usual Adult Dose for Systemic Mastocytosis

Initial dose: 200 mg (2 ampules) orally one-half hour before meals and at bedtime

• If satisfactory control is not achieved within 2 to 3 weeks, may increase dose.

Maintenance dose: May reduce dose to the minimum required to maintain adequate control once a therapeutic response has been achieved.
Maximum dose: 40 mg/kg/day

Comment:

• Use of this product has been associated with improvement in diarrhea, flushing, headaches, vomiting, urticaria, abdominal pain, nausea, and itching in some patients.

Use: For the management of patients with mastocytosis.

Usual Pediatric Dose for Asthma - Maintenance

Age: 2 years or older:

Administer 20 mg (1 vial) via nebulizer 4 times a day at regular intervals

Prophylaxis of acute bronchospasm due to exercise, exposure to cold dry air, or environmental allergens: 20 mg (1 vial) via nebulizer shortly before anticipated exposure

Comments:

• This drug is a prophylactic agent to be used in patients whose symptoms are sufficiently frequent to require a continuous regimen of medications; the effect is usually evident after several weeks, although some patients show an almost immediate response.
• This drug should not be added to a therapeutic regimen during an acute episode; therapy should be started once asthma is controlled, the airway is cleared, and the patient is able to inhale adequately.

Use: For the management of bronchial asthma

Usual Pediatric Dose for Systemic Mastocytosis

Age: 2 to 12 years old:
Initial dose: 100 mg (1 ampule) orally one-half hour before meals and at bedtime

Age: 13 years or older:
Initial dose: 200 mg (2 ampules) orally one-half hour before meals and at bedtime

• If satisfactory control is not achieved within 2 to 3 weeks, may increase dose to no more than 40 mg/kg/day.

Maintenance dose: Once a therapeutic response has been achieved, the dose may be reduced to the minimum required to maintain adequate control.
Maximum dose: 40 mg/kg/day

Comment:

• Use of this product has been associated with improvement in diarrhea, flushing, headaches, vomiting, urticaria, abdominal pain, nausea, and itching in some patients.
• Not recommended for patients less than 2 years of age unless the potential benefits clearly outweigh the risks.

Use: For the management of patients with mastocytosis.

Renal Dose Adjustments

Use with caution; consider decreasing oral dose in patients with renal impairment.

Liver Dose Adjustments

Use with caution; consider decreasing oral dose in patients with hepatic impairment.

Precautions

Safety and efficacy have not been established in patients younger than 2 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:
Orally:

• Take orally 30 minutes before meals and at bedtime.
• Oral liquid is supplied in ampules (100 mg/5 mL) for oral use only; not for inhalation or injection.
• At time of use, break open ampule(s) and squeeze contents into a glass of water; drink all liquid.

Nebulizer:

• Administer via nebulization 4 times a day.
• Solution for nebulization is supplied in vials (20 mg/2 mL) for oral inhalation only; not for injection.
• This drug should be administered via a power driven nebulizer at an airflow of 6 to 8 L/min with a suitable face mask; hand-operated nebulizers are not suitable for administration.

Storage requirements:

• Protect from light; store vials/ampules in foil pouches until ready to use
• Do not use if the solution is discolored or contains a precipitate.

• Stability and safety of this drug when mixed with other drugs in a nebulizer have not been established.

General:

• This is a prophylactic agent and has no role in the acute treatment of asthma.
• Effectiveness is dependent upon administration at regular intervals.

Monitoring:

• Monitor for control of symptoms; once symptoms are controlled, dose may be reduced to the minimum required to maintain the patient with a lower degree of symptomatology.

Patient advice:

• Patients should understand that this drug is a preventative agent, it may take 2 to 4 weeks to see benefit; effectiveness is dependent on regular administration.
• Patients with acute symptoms should seek medical advice promptly.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer